FDA, Danco Oppose States’ Intervention In Abortion Drug Case In High Court
WASHINGTON, D.C. — Three anti-abortion states on Feb. 6 replied to oppositions filed by the U.S. Food and Drug Administration and by Danco Laboratories LLC, the manufacturer of Mifeprex-brand mifepristone, on...To view the full article, register now.
Already a subscriber? Click here to view full article